Trial intelligence / Profile preview

FluAS25 revaccination versus Fluarix in previously vaccinated elderly adults

2006-003237-32Phase 2Completed

Sponsor
GSK
Start
Oct 2006
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 2 trial of GSK576389A, Fluarix in influenza, sponsored by GSK. Started Oct 2006; status: completed.

02

Drugs

GSK576389AFluarix
03

Conditions

influenza

Beyond the preview

Go deeper on 2006-003237-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-003237-32.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call